NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

3 hedge funds and large institutions have $4.95K invested in NeuBase Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 17 closing their positions.

Holders
3
Holders Change
-16
Holders Change %
-84.21%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
1
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BBA
1
Baader Bank Aktiengesellschaft
Germany
$4.95K 16,089 +16,089 New
DCM
2
DME Capital Management
New York
-136,350 Closed
Renaissance Technologies
3
Renaissance Technologies
New York
-88,229 Closed
Point72 Asset Management
4
Point72 Asset Management
Connecticut
-62,500 Closed
CMU
5
Carnegie Mellon University
Pennsylvania
-46,970 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
-18,981 Closed
PCM
7
Prelude Capital Management
New York
-15,550 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
-15,482 Closed
UBS Group
9
UBS Group
Switzerland
-4,056 Closed
TRCT
10
Tower Research Capital (TRC)
New York
-2,572 Closed
CSS
11
Cubist Systematic Strategies
Connecticut
-1,251 Closed
Bank of America
12
Bank of America
North Carolina
-804 Closed
First Manhattan
13
First Manhattan
New York
-353 Closed
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
-153 Closed
Wells Fargo
15
Wells Fargo
California
-79 Closed
Osaic Holdings
16
Osaic Holdings
Arizona
$0 1 -21 -95%
PNC Financial Services Group
17
PNC Financial Services Group
Pennsylvania
-21 Closed
NFSG
18
Newbridge Financial Services Group
Florida
-12 Closed
Morgan Stanley
19
Morgan Stanley
New York
-9 Closed
CFGS
20
Concourse Financial Group Securities
Alabama
HNB
21
Huntington National Bank
Ohio
$0 1